175 related articles for article (PubMed ID: 19837953)
1. Inhibition of matrix metalloproteinase activity in vivo protects against vascular hyporeactivity in endotoxemia.
Cena JJ; Lalu MM; Cho WJ; Chow AK; Bagdan ML; Daniel EE; Castro MM; Schulz R
Am J Physiol Heart Circ Physiol; 2010 Jan; 298(1):H45-51. PubMed ID: 19837953
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases contribute to endotoxin and interleukin-1beta induced vascular dysfunction.
Lalu MM; Cena J; Chowdhury R; Lam A; Schulz R
Br J Pharmacol; 2006 Sep; 149(1):31-42. PubMed ID: 16880766
[TBL] [Abstract][Full Text] [Related]
3. Endothelial dependence of matrix metalloproteinase-mediated vascular hyporeactivity caused by lipopolysaccharide.
Cena J; Lalu MM; Rosenfelt C; Schulz R
Eur J Pharmacol; 2008 Mar; 582(1-3):116-22. PubMed ID: 18242597
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase-2 proteolysis of calponin-1 contributes to vascular hypocontractility in endotoxemic rats.
Castro MM; Cena J; Cho WJ; Walsh MP; Schulz R
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):662-8. PubMed ID: 22199370
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase activities are altered in the heart and plasma during endotoxemia.
Lalu MM; Csont T; Schulz R
Crit Care Med; 2004 Jun; 32(6):1332-7. PubMed ID: 15187516
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase inhibitors attenuate endotoxemia induced cardiac dysfunction: a potential role for MMP-9.
Lalu MM; Gao CQ; Schulz R
Mol Cell Biochem; 2003 Sep; 251(1-2):61-6. PubMed ID: 14575305
[TBL] [Abstract][Full Text] [Related]
7. Andrographolide protects against lipopolysaccharide-induced vascular hyporeactivity by suppressing the expression of inducible nitric oxide in periaortic adipose.
Hai-Mei L; Song-Yin H; Run-Mei L; Xiao-Huang X; Le-Quan Z; Xiao-Ping L; Jin-Wen X
J Cardiovasc Pharmacol; 2013 Aug; 62(2):154-9. PubMed ID: 23575260
[TBL] [Abstract][Full Text] [Related]
8. The lazaroid, U-74389G, inhibits inducible nitric oxide synthase activity, reverses vascular failure and protects against endotoxin shock.
Altavilla D; Squadrito F; Campo GM; Squadrito G; Arlotta M; Urna G; Sardella A; Quartarone C; Saitta A; Caputi AP
Eur J Pharmacol; 1999 Mar; 369(1):49-55. PubMed ID: 10204681
[TBL] [Abstract][Full Text] [Related]
9. Terlipressin inhibits in vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosis.
Moreau R; Barrière E; Tazi KA; Lardeux B; Dargère D; Urbanowicz W; Poirel O; Chauvelot-Moachon L; Guimont MC; Bernuau D; Lebrec D
Hepatology; 2002 Nov; 36(5):1070-8. PubMed ID: 12395316
[TBL] [Abstract][Full Text] [Related]
10. Hyporesponsiveness to Ca2+ of aortic smooth muscle in endotoxin-treated rats: no-dependent and -independent in vitro mechanisms.
Ho KH; Kwan CY; Bourreau JP
Res Commun Mol Pathol Pharmacol; 1996 Jun; 92(3):275-84. PubMed ID: 8827826
[TBL] [Abstract][Full Text] [Related]
11. Inducible nitric oxide synthase and vascular reactivity in rat thoracic aorta: effect of aminoguanidine.
Scott JA; Machoun M; McCormack DG
J Appl Physiol (1985); 1996 Jan; 80(1):271-7. PubMed ID: 8847314
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide-independent activation of soluble guanylyl cyclase contributes to endotoxin shock in rats.
Wu CC; Chen SJ; Yen MH
Am J Physiol; 1998 Oct; 275(4):H1148-57. PubMed ID: 9746461
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase inhibitors prevent sepsis-induced refractoriness to vasoconstrictors in the cecal ligation and puncture model in rats.
de Souza P; Schulz R; da Silva-Santos JE
Eur J Pharmacol; 2015 Oct; 765():164-70. PubMed ID: 26297976
[TBL] [Abstract][Full Text] [Related]
14. The apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats.
Dai L; Datta G; Zhang Z; Gupta H; Patel R; Honavar J; Modi S; Wyss JM; Palgunachari M; Anantharamaiah GM; White CR
J Lipid Res; 2010 Sep; 51(9):2695-705. PubMed ID: 20495214
[TBL] [Abstract][Full Text] [Related]
15. Smoothelin-B is not a target of matrix metalloproteinase (MMP)-2 in the vasculature of endotoxemic rats.
de Souza P; Mazzaron de Castro M; Goobie G; da Silva-Santos JE; Schulz R
Can J Physiol Pharmacol; 2014 Oct; 92(10):887-91. PubMed ID: 25272092
[TBL] [Abstract][Full Text] [Related]
16. Expression and preferential inhibition of inducible nitric oxide synthase in aortas of endotoxemic rats.
Weigert AL; Higa EM; Niederberger M; McMurtry IF; Raynolds M; Schrier RW
J Am Soc Nephrol; 1995 Jun; 5(12):2067-72. PubMed ID: 7579055
[TBL] [Abstract][Full Text] [Related]
17. Effects of SPAK on vascular reactivity and nitric oxide production in endotoxemic mice.
Shih CC; Hsu LP; Liao MH; Yang SS; Ho ST; Wu CC
Eur J Pharmacol; 2017 Nov; 814():248-254. PubMed ID: 28864211
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of endotoxin-induced vascular hyporeactivity to phenylephrine in the thoracic aortas of Mg-deficient rats ex vivo.
Miyamoto A; Yamazaki Y; Takagi T; Ishiguro S; Nishio A
Life Sci; 2003 Oct; 73(21):2713-26. PubMed ID: 13679239
[TBL] [Abstract][Full Text] [Related]
19. Effect of NOS inhibition on rat gastric matrix metalloproteinase production during endotoxemia.
Robinson EK; Seaworth CM; Suliburk JW; Adams SD; Kao LS; Mercer DW
Shock; 2006 May; 25(5):507-14. PubMed ID: 16680016
[TBL] [Abstract][Full Text] [Related]
20. Abnormal activation of Na+-K+ pump in aortas from rats with endotoxaemia.
Chen SJ; Chen KH; Webb RC; Yen MH; Wu CC
Naunyn Schmiedebergs Arch Pharmacol; 2003 Jul; 368(1):57-62. PubMed ID: 12838383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
